mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.2 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.2 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |